Wednesday, February 10, 2010, 2:43PM AEST - The Australian Stockmarket closes in 1 hour and 22 minutes.
To create a watchlist or portfolio of shares, Register

Simcere Pharmaceutical Group. (SCR)

8:03AM AEST: 8.88 USD  Up 0.26 (3.02%)  
 MORE ON SCR 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 SIMCERE PHARMA ADS (NYSE:SCR) Delayed quote dataEdit
Last Trade:8.88 USD
Trade Time: 8:03AM AEST
Change:Up 0.26 (3.02%)
Prev Close:8.62
Open:8.67
Bid:N/A
Ask:N/A
1y Target Est:7.47
Day's Range:8.60 - 9.03
52wk Range:4.76 - 10.03
Volume:40,709
Avg Vol (3m):104,786
Market Cap:500.49M
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add SCR to Portfolio   Download Data

 HEADLINES 
Simcere Pharma downgraded by Oppenheimer
Briefing.com (Fri, Jan 22)
Today's 5-Star Movers
at Motley Fool (Wed, Jan 13)
China Sky One Medical, Inc. - Executive Interview, Yan-Qing Liu and Stanley Hao
Wall Street Transcript (Thu, Dec 10)
Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
PR Newswire (Thu, Dec 3)
Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List
PR Newswire (Wed, Dec 2)
Simcere suspends production at Yanshen unit
AP (Wed, Dec 2)
Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production
PR Newswire (Wed, Dec 2)
New Star Analyst Rankings for SIMCERE PHARMA ADS
StarMine (Wed, Nov 18)
Earnings roundup: Tween Brands, Perfect World
AP (Tue, Nov 17)
Simcere Pharmaceutical 3Q profit falls on costs
AP (Tue, Nov 17)
More Headlines for SCR...

 ANALYST 
EPS Est (next year) (Dec-09) :0.34
EPS Est (in 2 years) (Dec-10) :0.43
Avg Rec (current)*:2.7
PEG Ratio:2.82
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Simcere Pharmaceutical Group engages in the research, development, manufacture, distribution, and marketing of branded generic pharmaceutical products in the People’s Republic of China.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices